Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Trial of Docosahexaenoic Acid Supplementation in Children With Autism.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Docosahexaenoic acid (Primary)
- Indications Autistic disorder
- Focus Therapeutic Use
- 24 May 2011 New trial record